浙江医药：拟16.85亿元投建昌北生物建设项目

Core Viewpoint - The company aims to enhance its self-sufficiency in raw materials for vitamins and reduce reliance on external intermediates through a significant investment project [1] Investment Project Summary - Zhejiang Changbei Biological Co., Ltd., a subsidiary of the company, plans to invest approximately 168.5 million yuan in the construction of a project to produce vitamin intermediates [1] - The project is expected to generate annual sales of 900 million yuan and a gross profit of 286 million yuan upon completion [1] - This investment decision aligns with the company's strategic development and business layout, although future operational effectiveness carries some uncertainty [1]